v3.25.3
Stockholders’ (Deficit) Equity (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Aug. 01, 2025
Jul. 11, 2025
Jul. 08, 2025
Jun. 24, 2025
May 01, 2025
Mar. 20, 2025
Mar. 07, 2025
Feb. 02, 2025
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
May 13, 2025
Apr. 11, 2025
Nov. 05, 2024
Nov. 04, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Gross proceeds warrants       $ 10,000,000.0               $ 2,672,500        
Fair value       265,957                          
Additional issuance costs       $ 74,000                          
Stock based compensation expense                 $ 73,988   $ 160,665 205,478 544,902        
Unrecognized stock-based compensation expense                 $ 317,710     $ 317,710          
Weighted average period   3 years                   1 year 10 months 24 days          
Exercise price     $ 1.00                            
Gross proceeds                       $ 1,999,791        
Warrant term                 5 years     5 years          
Other costs                 $ 175,221 $ 282,849 427,054            
Inducement Warrants [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Exercise price     $ 0.67                            
Other fees     $ 41,851                            
Number of shares of common stock issued pursuant to the holder's exercise of existing warrants rate     $ 2                            
March 2025 PreFunded Warrants [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Exercise price                 $ 0.0001     $ 0.0001          
December 2023 Offering [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Gross proceeds warrants   $ 201,296                              
Private Placement [Member] | March 2025 PreFunded Warrants [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Exercise price             $ 0.0001                    
Warrant purchase             2,105,265                    
Transaction costs                       $ 282,849          
Placement fees                       199,863          
Other fees                       56,844          
Other costs                       26,142          
Private Placement [Member] | March 2025 Common Warrants [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrant purchase             2,105,265                    
Private Placement [Member] | March 2025 Common Warrants And Prefunded Warrants [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Exercise price             $ 0.9499                 $ 1.00 $ 2.06
Warrant purchase                               957,200  
Gross proceeds             $ 2,000,000.0                    
Transaction costs             $ 53,890                    
Research and Development Expense [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock based compensation expense                 $ 17,362   15,447 48,256 46,342        
General and Administrative Expense [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock based compensation expense                 $ 56,626   $ 145,218 $ 157,222 $ 498,560        
Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrant modification costs     $ 1,762,756                            
Warrant [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Purchase of warrants   377,964   426,829                          
Exercise price   $ 0.59                              
Series A2 Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrant purchase     957,200                            
Series A3 Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Warrant purchase     2,105,265                            
Series A4 Common Stock [Member] | Inducement Warrants [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Exercise price     $ 0.67                            
Warrant purchase     6,124,930                            
Transaction costs     $ 175,221                            
Warrant term     5 years                            
Proceeds from issuance of common stock     $ 2,051,852                            
Cash fee paid     $ 133,370                            
Marketing Agreements [Member] | Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock issued period of shares, common stock 160,000       100,000 100,000   60,000                  
Prepaid expense $ 29,600       $ 51,800 $ 70,100   $ 81,600                  
Number of common stock for future issuance 160,000                         100,000 100,000    
Vendor market value $ 29,600                         $ 51,800 $ 77,000    
Equity Purchase Agreement [Member] | ELOC Shares [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Gross proceeds warrants       $ 10,000,000.0